Richard Chin

Richard H.
Chin was the founder of Kindred Biosciences, Inc., founded in 2012, where the titles held included President, Chief Executive Officer & Director from 2020 to 2021.
Current jobs include Independent Director at Cytek Biosciences, Inc. starting in 2025 and Associate Professor at The University of California, San Francisco.
Former jobs include President, Chief Executive Officer & Secretary at Oncotelic Therapeutics, Inc. from 2006 to 2008; Chief Executive Officer at Gates Foundation Trust from 2008 to 2011; Chief Executive Officer at PATH Drug Solutions from 2008 to 2011; Group Director & Head-Clinical Research at Genentech, Inc. from 1999 to 2004; Independent Director at ImmunoCellular Therapeutics Ltd. from 2012 to 2015; Independent Director at Galena Biopharma, Inc. from 2009 to 2017; Associate Medical Director at Procter & Gamble Pharmaceuticals, Inc.; Director at Genmedica Therapeutics SL; Director at Nacuity Pharmaceuticals, Inc.; Chief Accounting Officer & Vice President-Finance at Telik, Inc.; Director at Balance Therapeutics, Inc. from 2011 to 2018; and Senior Vice President-Global Development at Elan Pharmaceuticals LLC from 2004 to 2006.
Education includes doctorate degrees from Harvard University and Harvard Medical School, and graduate studies at the University of Oxford.